101 related articles for article (PubMed ID: 9781361)
1. A helical region on human lactoferrin. Its role in antibacterial pathogenesis.
Chapple DS; Joannou CL; Mason DJ; Shergill JK; Odell EW; Gant V; Evans RW
Adv Exp Med Biol; 1998; 443():215-20. PubMed ID: 9781361
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.
Chapple DS; Mason DJ; Joannou CL; Odell EW; Gant V; Evans RW
Infect Immun; 1998 Jun; 66(6):2434-40. PubMed ID: 9596699
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of peptides homologous to a loop region in human lactoferrin.
Odell EW; Sarra R; Foxworthy M; Chapple DS; Evans RW
FEBS Lett; 1996 Mar; 382(1-2):175-8. PubMed ID: 8612745
[TBL] [Abstract][Full Text] [Related]
4. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
5. Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.
Chapple DS; Hussain R; Joannou CL; Hancock RE; Odell E; Evans RW; Siligardi G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2190-8. PubMed ID: 15155221
[TBL] [Abstract][Full Text] [Related]
6. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial action of lactoferricin B like peptide against Escherichia coli: reactive oxygen species-induced apoptosis-like death.
Lee B; Hwang JS; Lee DG
J Appl Microbiol; 2020 Aug; 129(2):287-295. PubMed ID: 32145045
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin.
Azuma M; Kojima T; Yokoyama I; Tajiri H; Yoshikawa K; Saga S; Del Carpio CA
J Pept Res; 1999 Sep; 54(3):237-41. PubMed ID: 10517161
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
[TBL] [Abstract][Full Text] [Related]
12. Influence of specific amino acid side-chains on the antimicrobial activity and structure of bovine lactoferrampin.
Haney EF; Nazmi K; Bolscher JG; Vogel HJ
Biochem Cell Biol; 2012 Jun; 90(3):362-77. PubMed ID: 22250712
[TBL] [Abstract][Full Text] [Related]
13. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
Lejon T; Svendsen JS; Haug BE
J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
[TBL] [Abstract][Full Text] [Related]
14. Increased antibacterial activity of 15-residue murine lactoferricin derivatives.
Strøm MB; Rekdal O; Stensen W; Svendsen JS
J Pept Res; 2001 Feb; 57(2):127-39. PubMed ID: 11168896
[TBL] [Abstract][Full Text] [Related]
15. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.
Håversen L; Kondori N; Baltzer L; Hanson LA; Dolphin GT; Dunér K; Mattsby-Baltzer I
Antimicrob Agents Chemother; 2010 Jan; 54(1):418-25. PubMed ID: 19917761
[TBL] [Abstract][Full Text] [Related]
16. Homology similarity analysis of sequences of lactoferricin and its derivatives.
Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
[TBL] [Abstract][Full Text] [Related]
17. A review: the active peptide of lactoferrin.
Tomita M; Takase M; Bellamy W; Shimamura S
Acta Paediatr Jpn; 1994 Oct; 36(5):585-91. PubMed ID: 7825467
[TBL] [Abstract][Full Text] [Related]
18. Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.
Han FF; Gao YH; Luan C; Xie YG; Liu YF; Wang YZ
J Dairy Sci; 2013 Jun; 96(6):3471-87. PubMed ID: 23567049
[TBL] [Abstract][Full Text] [Related]
19. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin.
Kang JH; Lee MK; Kim KL; Hahm KS
Int J Pept Protein Res; 1996 Oct; 48(4):357-63. PubMed ID: 8919056
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
